Arrhythmogenic Ventricular Tachycardia Right Ventricular Cardiomyopathy: How to Manage?

Main Article Content

Manimekalai P
Isabella Rita
Vinatha MC
B.V. Purnesh
N Lakshmi Prashanth

Abstract

The shape has been distinguished as “Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)” by the RV myocardium fibrofatty replacement due to gene disease. Changes in structure can be minor in alternatives absent of the disease's premature stages and be contained in the RV-particular region. It has been recognized that Clinically emerges as the RV electrical fluctuation. Decreasing arrhythmic events risk or alternative sudden death for cardiac, therapy of device and physiotherapy may be advocated. The patient dispenses with cardiovascular disease that has been accompanied by pulsation. It has been presented that a cardiogram or ECG ventricular tachycardia of RV apex origin, and the changes in the symmetric transpose T-waves and also the probable epsilon waves into the right precordial leads, mimicking a pseudo- “right bundle branch block (RBBB)” is a way that is following electrical cardioversion. The short axis of the parasternal echocardiography view shows severe right ventricular distend. We identify these types of patients with ventricular cardiac infraction on the backside of the suspicious arrhythmogenic right ventricular cardiomyopathy. We were able to produce correct recognition and treatments, and circumvent certainly fatal repercussions.

Article Details

How to Cite
Manimekalai P, Isabella Rita, Vinatha MC, B.V. Purnesh, & N Lakshmi Prashanth. (2023). Arrhythmogenic Ventricular Tachycardia Right Ventricular Cardiomyopathy: How to Manage?. Journal of Coastal Life Medicine, 11(2), 950–953. Retrieved from https://www.jclmm.com/index.php/journal/article/view/1112
Section
Articles

References

James CA, Calkins H. Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C). Curr Treat Options Cardiovasc Med. 2013;15:476–487.

Cadrin-Tourigny J, Bosman LP, Wang W, et al. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): A Multinational Collaboration. Circ Arrhythm Electrophysiol. 2020 Dec 9.

Que D, Yang P, Song X, et al. Traditional vs. genetic pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Europace. 2015;17:1770–1776.

Gasperetti A, James CA, Cerrone M, et al. Arrhythmogenic right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry. Eur Heart J. 2020 Nov 17:ehaa821

Assis FR, Tandri H. Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy. Assis FR, Tandri H. Card Electrophysiol Clin. 2020 Sep;12(3):329-343.

Malik N, Win S, James CA, et al. Right Ventricular Strain Predicts Structural Disease Progression in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Heart Assoc. 2020 Apr 7;9(7):e015016

James CA, Bhonsale A, Tichnell C, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62:1290–1297.